ORIC — Oric Pharmaceuticals Inc

Ownership history in MPM BioImpact LLC  ·  4 quarters on record

This page tracks every 13F SEC filing in which MPM BioImpact LLC reported a position in Oric Pharmaceuticals Inc (ORIC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
3.4% (2025 Q3)
Avg. % of fund
2.37%
First filed
2025 Q1
Last filed
2025 Q4
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 1,798,717 +69,339 +4.0% 1.68% $14.7M $8.18
2025 Q3 UNCHANGED 1,729,378 — 0% 3.40% $20.8M $12.00
2025 Q2 ADDED 1,729,378 +329,864 +23.6% 3.04% $17.6M $10.15
2025 Q1 INITIATED 1,399,514 — — 1.34% $7.8M $5.58
% of Fund (quarterly)    ORIC price (monthly, adj. close)

Other funds also holding ORIC

As of 2025 Q4 — sorted by position size

Column Group LLC 3Y 34.98% PFIZER INC 18.6% SR ONE CAPITAL MANAGEMENT, LP 3Y 5.34% EcoR1 Capital, LLC 3Y 7Y 2.5% VR Adviser, LLC 3Y 2.29% Euclidean Capital LLC 3Y 2.19% First Turn Management, LLC 1.88% NEA Management Company, LLC 3Y 7Y 1.72% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 1.59% SILVERARC CAPITAL MANAGEMENT, LLC 3Y 1.27%
← Back to MPM BioImpact LLC Holdings